跳至主要内容
临床试验/NCT05268549
NCT05268549Unknown不适用

Independent Risk Factors Analysis and Model Construction For Recurrence After Radiofrequency/Microwave Ablation of Colorectal Cancer With Liver Metastases: a Retrospective, Multicenter Trial

The Central Hospital of Lishui City0 个研究点目标入组 80 人开始时间: 2022年3月12日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
80
主要终点
The first recurrence of colorectal cancer with liver metastasis (CRLM) after radiofrequency/microwave ablation, assessed up to 18 months

研究概览

简要总结

This study is a retrospective, multicenter clinical study. The main objective is to analyze the risk factors affecting the recurrence of colorectal cancer patients with liver metastases who received radiofrequency/microwave ablation. Finally, we will construct a recurrence risk prediction model based on the risk factors and validated the model.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age:older than 18 years;
  • Patients with a single tumor diameter ≤5cm, no more than 3 tumor nodules, and the largest tumor diameter ≤3cm;
  • Absence of vessel, bile duct and adjacent organ invasion and distant metastasis;
  • The primary tumor of colorectal cancer has been resected, the liver metastases cannot be resected or the patient is unwilling to undergo surgery (clinical or pathological confirmation);
  • Normal coagulation status and liver function child-pugh A or B;
  • Liver metastases have not received other antitumor therapy after radiofrequency/microwave therapy (before disease progression);
  • Routine laboratory tests were performed before the first RF/microwave treatment;
  • Follow up for more than 12 months;
  • Obtained free informed consent.

排除标准

  • Large tumor, or diffuse intrahepatic metastasis;
  • Accompanied by vascular tumor thrombus or invasion of adjacent organs;
  • The primary tumor of colorectal cancer has not been resected, with extrahepatic metastasis;
  • Uncorrectable coagulation dysfunction and severe blood abnormalities, those with severe bleeding tendency;
  • Intractable massive ascites, cachexia;
  • Active infection, especially inflammation of the biliary system;
  • Severe liver, kidney, heart, lung, brain and other major organ failure;
  • Patients with impaired consciousness or unable to cooperate with treatment;
  • Missing follow-up data.

结局指标

主要结局

The first recurrence of colorectal cancer with liver metastasis (CRLM) after radiofrequency/microwave ablation, assessed up to 18 months

时间窗: Time from enrollment to disease recurrence, assessed up to 18 months

The first recurrence of colorectal cancer with liver metastasis (CRLM) after radiofrequency/microwave ablation, assessed up to 18 months

次要结局

  • Patients with colorectal cancer with liver metastases (CRLM) developed new metastases after radiofrequency/microwave ablation,assessed up to 18 months(Time from enrollment to developed new metastases, assessed up to 18 months)

研究者

发起方
The Central Hospital of Lishui City
申办方类型
Other
责任方
Sponsor

相似试验

Independent Risk Factors Analysis and Model... | 临床试验